NEW YORK, Feb. 26, 2018 /PRNewswire/ -- Oppenheimer
& Co. Inc. ("Oppenheimer") – a leading wealth manager and
investment bank and a subsidiary of Oppenheimer Holdings (NYSE:OPY)
– today announced Leland Gershell,
M.D., Ph.D. joined the Firm as Managing Director and Senior Analyst
on the Life Sciences research team. With extensive experience in
the field, he is responsible for expanding and distinguishing
Oppenheimer's Life Sciences research product.
Gershell joins from Capricor Therapeutics, which develops
therapies for rare pediatric diseases, and previously served as CFO
of Tonix Pharmaceuticals, a company developing small-molecule drug
candidates for neuropsychiatric disorders. His achievements include
raising over $140 million across a
variety of equity financing mechanisms and securing investment
participation from leading Life Science institutions. Prior to his
corporate roles, Leland covered a variety of biotechnology and
pharmaceutical companies as both a sell-side and buy-side
analyst.
"This is a very dynamic time in the healthcare sector, with new
therapies poised to revolutionize business models, as well as the
continued focus on technology innovation using artificial
intelligence and big data," said John
Parks, Managing Director & Director of Equity Research
at Oppenheimer. "Leland's experience, both financial and corporate,
will help guide the Life Sciences research team through this era of
change and help expand Oppenheimer's research offerings."
Healthcare and Life Sciences has historically been a strong
focus for the Firm. Oppenheimer reaffirmed its commitment to
Healthcare Investment Banking last year with a series of new
hires.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary
of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange),
and its affiliates provide a full range of wealth management,
securities brokerage and investment banking services to
high-net-worth individuals, families, corporate executives, local
governments, businesses and institutions.
View original
content:http://www.prnewswire.com/news-releases/oppenheimer-strengthens-life-sciences-team-with-new-managing-director-300603628.html
SOURCE Oppenheimer & Co. Inc.